oxalic acid has been researched along with Kidney Diseases in 20 studies
Oxalic Acid: A strong dicarboxylic acid occurring in many plants and vegetables. It is produced in the body by metabolism of glyoxylic acid or ascorbic acid. It is not metabolized but excreted in the urine. It is used as an analytical reagent and general reducing agent.
oxalic acid : An alpha,omega-dicarboxylic acid that is ethane substituted by carboxyl groups at positions 1 and 2.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "However, the clinical significance of recurrence is often minor." | 2.37 | [Recurrence of the original disease in the transplanted kidney]. ( Briner, J; Leumann, EP, 1984) |
| " The development and evaluation of the PBPK model was based upon previously published pharmacokinetic studies coupled with measured blood and tissue partition coefficients and rates of in vitro metabolism of glyoxylic acid to oxalic acid, glycine and other metabolites using primary hepatocytes isolated from male Wistar rats and humans." | 1.37 | Extension of a PBPK model for ethylene glycol and glycolic acid to include the competitive formation and clearance of metabolites associated with kidney toxicity in rats and humans. ( Bartels, MJ; Corley, RA; Creim, J; Hansen, SC; McMartin, KE; Saghir, SA; Snellings, WM, 2011) |
| "Oxalic acid is thought to be a significant uremic toxin that participates in the pathogenesis of uremic syndrome." | 1.36 | [Oxalic acid--important uremic toxin]. ( Derzsiová, K; Mydlík, M, 2010) |
| "Ethylene glycol was mixed in the diet at concentrations to deliver constant target dosage levels of 0, 50, 150, 500, or 1000 mg/kg/day for 16 weeks to groups of 10 male Wistar and 10 male F-344 rats based on weekly group mean body weights and feed consumption." | 1.32 | Subchronic toxicity of ethylene glycol in Wistar and F-344 rats related to metabolism and clearance of metabolites. ( Corley, RA; Cruzan, G; Deyo, JA; Gingell, R; Hard, GC; McMartin, KE; Mertens, JJ; Snellings, WM, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (40.00) | 18.7374 |
| 1990's | 4 (20.00) | 18.2507 |
| 2000's | 3 (15.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kwan, TK | 1 |
| Chadban, SJ | 1 |
| McKenzie, PR | 1 |
| Saunders, JR | 1 |
| Mydlík, M | 4 |
| Derzsiová, K | 4 |
| Corley, RA | 2 |
| Saghir, SA | 1 |
| Bartels, MJ | 1 |
| Hansen, SC | 1 |
| Creim, J | 1 |
| McMartin, KE | 2 |
| Snellings, WM | 2 |
| BRUSCAGLI, G | 1 |
| DINI, S | 1 |
| TERZANI, E | 1 |
| Cruzan, G | 1 |
| Hard, GC | 1 |
| Mertens, JJ | 1 |
| Gingell, R | 1 |
| Deyo, JA | 1 |
| Mazze, RI | 1 |
| Leumann, EP | 1 |
| Briner, J | 1 |
| Drenick, EJ | 1 |
| Stanley, TM | 1 |
| Wills, CE | 1 |
| Wolthers, BG | 1 |
| Hayer, M | 1 |
| Scholtens, R | 1 |
| Scholten, J | 1 |
| de Koning, HW | 1 |
| Tijssen, J | 1 |
| ten Hoopen, HW | 1 |
| Olthuis, FM | 1 |
| Feijen, J | 1 |
| Lalli, AF | 1 |
| Okugawa, T | 1 |
| Uchiyama, M | 1 |
| Raghavan, KG | 1 |
| Lathika, KM | 1 |
| Gandhi, NM | 1 |
| D'Souza, SJ | 1 |
| Tarachand, U | 1 |
| Ramakrishnan, V | 1 |
| Singh, BB | 1 |
| Ogawa, Y | 1 |
| Hatano, T | 1 |
| Neĭko, EM | 1 |
| Del'va, IuV | 1 |
| Baĭgil'dina, LM | 1 |
| Boer, P | 1 |
| Prenen, JA | 1 |
| Koomans, HA | 1 |
| Dorhout Mees, EJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Determination of Analgesic Equipotent Doses of Inhaled Metoxyflurane vs. Intravenous Fentanyl Using Cold Pressor Test (CPT) in Volunteers: A Randomized, Double Blind, Placebo-controlled Crossover Study.[NCT03894800] | Phase 4 | 12 participants (Actual) | Interventional | 2019-04-23 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for oxalic acid and Kidney Diseases
| Article | Year |
|---|---|
[Recurrence of the original disease in the transplanted kidney].
Topics: Anti-Glomerular Basement Membrane Disease; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; | 1984 |
[Hyperoxaluria].
Topics: Aluminum; Humans; Hyperoxaluria; Kidney Diseases; Oxalates; Oxalic Acid | 1997 |
[Primary hyperoxaluria type 2(PH2)].
Topics: Alcohol Oxidoreductases; Biomarkers; Diagnosis, Differential; Glyceric Acids; Humans; Hyperoxaluria; | 1998 |
[Oxalic acid metabolic disorder in kidney diseases].
Topics: Disease Susceptibility; Humans; Kidney; Kidney Calculi; Kidney Diseases; Oxalates; Oxalic Acid | 1991 |
16 other studies available for oxalic acid and Kidney Diseases
| Article | Year |
|---|---|
Acute oxalate nephropathy secondary to orlistat-induced enteric hyperoxaluria.
Topics: Anti-Obesity Agents; Biopsy; Diet; Female; Humans; Hyperoxaluria; Intestinal Mucosa; Intestines; Kid | 2013 |
Vitamin B6 and oxalic acid in clinical nephrology.
Topics: Adult; Dialysis Solutions; Erythrocytes; Female; Glomerulonephritis; Humans; Kidney Diseases; Male; | 2010 |
[Oxalic acid--important uremic toxin].
Topics: Adult; Ascorbic Acid; Chronic Disease; Creatinine; Diuresis; Female; Humans; Kidney Diseases; Kidney | 2010 |
Extension of a PBPK model for ethylene glycol and glycolic acid to include the competitive formation and clearance of metabolites associated with kidney toxicity in rats and humans.
Topics: Animals; Calcium Oxalate; Dose-Response Relationship, Drug; Drug Administration Routes; Ethylene Gly | 2011 |
Kidney damage in acute intermittent porphyria.
Topics: Adult; Female; Glucose; Humans; Kidney Diseases; Male; Oxalic Acid; Phenothiazines; Porphyria, Acute | 2011 |
[Chronic experimental nephropathy induced by oxalic acid and the influence of renal hyperfunction on it].
Topics: Humans; Kidney; Kidney Diseases; Kidney Failure, Chronic; Nephrectomy; Oxalates; Oxalic Acid; Renal | 1962 |
Subchronic toxicity of ethylene glycol in Wistar and F-344 rats related to metabolism and clearance of metabolites.
Topics: Animals; Biotransformation; Body Weight; Diet; Drinking; Ethylene Glycol; Glycolates; Kidney; Kidney | 2004 |
Methoxyflurane revisited: tale of an anesthetic from cradle to grave.
Topics: Anesthesiology; Anesthetics, Inhalation; Animals; Fluorides; History, 20th Century; Humans; Kidney D | 2006 |
Oxalic Acid as a uremic toxin.
Topics: Adult; Ascorbic Acid; Atherosclerosis; Creatinine; Female; Glomerulonephritis; Humans; Kidney Diseas | 2008 |
Renal damage after intestinal bypass.
Topics: Fluorescent Antibody Technique; Humans; Intestines; Kidney; Kidney Diseases; Kidney Glomerulus; Obes | 1981 |
The determination of oxalic acid in plasma and urine by means of capillary gas chromatography.
Topics: Adolescent; Adult; Child; Child, Preschool; Chromatography, Gas; Drug Stability; Glyoxylates; Humans | 1982 |
In vitro adsorption of oxalic acid and glyoxylic acid onto activated charcoal, resins and hydrous zirconium oxide.
Topics: Adsorption; Binding Sites; Charcoal; Glyoxylates; Hemoperfusion; Humans; Kidney Diseases; Microscopy | 1982 |
Renal Parenchyma calcifications.
Topics: Acidosis, Renal Tubular; Adult; Calcinosis; Female; Humans; Kidney Cortex Necrosis; Kidney Diseases; | 1982 |
Biogenesis of L-glyceric aciduria, oxalosis and renal injury in rats simulating type II primary hyperoxaluria.
Topics: Animals; Glyceric Acids; Glyoxylates; Hyperoxaluria; Kidney Diseases; L-Lactate Dehydrogenase; Lipid | 1997 |
[Metabolic nephropathy with oxalate-calcium crystalluria in children].
Topics: Calcium; Child; Crystallization; Humans; Kidney Diseases; Kidney Function Tests; Metabolism, Inborn | 1985 |
Fractional oxalate clearance in subjects with normal and impaired renal function.
Topics: Adolescent; Adult; Creatinine; Female; Humans; Kidney Calculi; Kidney Diseases; Male; Middle Aged; O | 1985 |